A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group. 2013

Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
Department of Ophthalmology, Rudolf Foundation Clinic, Juchgasse 25, 1030 Vienna, Austria. tina.aggermann@wienkav.at

BACKGROUND To compare the surgical outcomes and evaluate the effectiveness of two treatments for central retinal vein occlusion (CRVO), radial optic neurotomy (RON) and intravitreal triamcinolone (IVT), in comparison to natural history. METHODS A prospective, placebo-controlled, randomised and multi-center study. Patients with CRVO were treated in three groups - with either RON, a single intravitreal injection of 4 mg triamcinolone acetonide, or a placebo treatment. The main outcome measures were change of VA (visual acuity) and proportion of eyes with a significant improvement (defined as > 3 lines logMAR scale) of VA from baseline to month 12. RESULTS Ninety patients were included. Due to insufficient data, seven were excluded. Forty-seven percent (n = 18) of patients treated with RON showed an increase in VA, in comparison to 10 % (n = 2) of placebo-treated patients, and 20 % (n = 5) of patients treated with IVT. Significantly more patients showed an improvement in VA following RON than in the placebo group (p = 0.009). Significantly more patients showed an improvement in VA following RON than in the IVT group (p = 0.034). No significant difference was found when directly comparing improvement in VA following IVT and placebo (p = 0.667) treatment.Significantly (p = 0.007) more patients in the placebo group (35 %, n = 7) showed a deterioration (defined as > 3 lines LogMAR scale) in VA than patients in the RON group (8 %, n = 3). CONCLUSIONS Our study showed that following treatment with RON, patients with CRVO display a significantly better long-term VA than untreated patients and patients treated with a single dose of IVT.

UI MeSH Term Description Entries
D008297 Male Males
D009900 Optic Nerve The 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM. Cranial Nerve II,Second Cranial Nerve,Nervus Opticus,Cranial Nerve, Second,Cranial Nerves, Second,Nerve, Optic,Nerve, Second Cranial,Nerves, Optic,Nerves, Second Cranial,Optic Nerves,Second Cranial Nerves
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005451 Fluorescein Angiography Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature. Fluorescence Angiography,Fundus Fluorescence Photography,Angiography, Fluorescein,Angiography, Fluorescence,Fluorescence Photography, Fundus,Photography, Fundus Fluorescence
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012170 Retinal Vein Occlusion Blockage of the RETINAL VEIN. Those at high risk for this condition include patients with HYPERTENSION; DIABETES MELLITUS; ATHEROSCLEROSIS; and other CARDIOVASCULAR DISEASES. Branch Retinal Vein Occlusion,Branch Vein Occlusion,Central Retinal Vein Occlusion,Retinal Branch Vein Occlusion,Thrombosis, Retinal Vein,Retinal Vein Thrombosis,Branch Vein Occlusions,Occlusion, Branch Vein,Occlusion, Retinal Vein,Retinal Vein Occlusions,Retinal Vein Thromboses,Vein Occlusion, Branch,Vein Occlusion, Retinal,Vein Thrombosis, Retinal
D013508 Ophthalmologic Surgical Procedures Surgery performed on the eye or any of its parts. Ophthalmologic Surgical Procedure,Ophthalmological Surgical Procedures,Procedure, Ophthalmologic Surgical,Procedures, Ophthalmologic Surgical,Surgical Procedure, Ophthalmologic,Surgical Procedures, Ophthalmologic,Ophthalmological Surgical Procedure,Procedure, Ophthalmological Surgical,Procedures, Ophthalmological Surgical,Surgical Procedure, Ophthalmological,Surgical Procedures, Ophthalmological
D014222 Triamcinolone Acetonide An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. Azmacort,Cinonide,Kenacort A,Kenalog,Kenalog 40,Tricort-40,Acetonide, Triamcinolone,Tricort 40,Tricort40

Related Publications

Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
April 2009, Journal of ophthalmic & vision research,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
December 2002, Retina (Philadelphia, Pa.),
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
November 2003, American journal of ophthalmology,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
June 2004, American journal of ophthalmology,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
June 2003, Journal francais d'ophtalmologie,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
July 2004, International ophthalmology,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
October 2007, Klinische Monatsblatter fur Augenheilkunde,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
October 2004, Archives of ophthalmology (Chicago, Ill. : 1960),
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
April 2007, Klinische Monatsblatter fur Augenheilkunde,
Tina Aggermann, and Simon Brunner, and Ilse Krebs, and Paulina Haas, and Irene Womastek, and Werner Brannath, and Susanne Binder, and
September 2005, Indian journal of ophthalmology,
Copied contents to your clipboard!